Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trial
Eur Heart J
.
2023 Oct 14;44(39):3939-3941.
doi: 10.1093/eurheartj/ehad543.
Authors
Mayank Dalakoti
1
2
3
,
Roger Foo
1
2
;
RESET Consortium
Collaborators
RESET Consortium
:
Roger Sik Yin Foo
,
Derek John Hausenloy
,
Chin Woon Loong Calvin
,
Mark Dhinesh Muthiah
,
Dennis Wang
,
Roshni Rebecca Singaraja
,
Josip Car
,
Wenru Wang
,
Mayank Dalakoti
,
Ching Hui Sia
,
Lohendran Baskaran
,
Melvin Khee Shing Leow
,
Yohanes Eko Riyanto
,
Paul A Macary
,
Han Wei Hou
,
Chester Lee Drum
,
Arthur Mark Richards
,
Jasper Tromp
,
Julian Savulescu
,
Nicholas Chew
,
Chrishan Julian Alles Ramachandran
,
Jason Kai Wei Lee
,
Wustefeld Torsten
,
Yibin Wang
,
Haojie Yu
,
Liang Zhong
,
Carolyn Lam Su Ping
,
Yan Yee Mark Chan
,
Yock Young Dan
,
Khung Keong Yeo
,
Tee Joo Yeo
,
Pierce Chow Kah Hoe
,
Dean Ho
,
Wei Jie Jonathan Lee
,
Poh Loong Soong
,
Lieng Hsi Ling
,
Tin Mei Yeo
,
Sebastian Maurer-Stroh
,
Tobias Leong
,
Mukkesh Kumar
,
Jamie Lye
,
Boxiang Liu
Affiliations
1
National University Heart Centre, 5 Lower Kent Ridge Rd, Singapore 119074.
2
Cardiovascular Metabolic Disease Translational Research Programme, National University of Singapore, MD6, Level 8, 14 Medical Drive, Singapore 117599.
3
Ng Teng Fong General Hospital, Singapore.
PMID:
37675563
DOI:
10.1093/eurheartj/ehad543
No abstract available
Grants and funding
National Medical Research Council Large Collaborative